Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.

Wojtas B, Ferraz C, Stokowy T, Hauptmann S, Lange D, Dralle H, Musholt T, Jarzab B, Paschke R, Eszlinger M.

Mol Cell Endocrinol. 2014 May 5;388(1-2):1-9. doi: 10.1016/j.mce.2014.02.011. Epub 2014 Mar 12. Review.

PMID:
24631480
2.

miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.

Colamaio M, Borbone E, Russo L, Bianco M, Federico A, Califano D, Chiappetta G, Pallante P, Troncone G, Battista S, Fusco A.

J Clin Endocrinol Metab. 2011 Dec;96(12):E1915-24. doi: 10.1210/jc.2011-0408. Epub 2011 Sep 28.

PMID:
21956418
3.

In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.

Guo Z, Hardin H, Montemayor-Garcia C, Asioli S, Righi A, Maletta F, Sapino A, Lloyd RV.

Endocr Pathol. 2015 May;26(2):157-63. doi: 10.1007/s12022-015-9363-x.

PMID:
25771986
4.

miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.

Colamaio M, Puca F, Ragozzino E, Gemei M, Decaussin-Petrucci M, Aiello C, Bastos AU, Federico A, Chiappetta G, Del Vecchio L, Torregrossa L, Battista S, Fusco A.

J Clin Endocrinol Metab. 2015 Jan;100(1):E59-69. doi: 10.1210/jc.2014-2280.

PMID:
25238203
5.

Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis.

Ferraz C, Lorenz S, Wojtas B, Bornstein SR, Paschke R, Eszlinger M.

J Clin Endocrinol Metab. 2013 Jan;98(1):E8-16. doi: 10.1210/jc.2012-2564. Epub 2012 Nov 8.

PMID:
23144465
6.

Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.

Rossing M, Borup R, Henao R, Winther O, Vikesaa J, Niazi O, Godballe C, Krogdahl A, Glud M, Hjort-Sørensen C, Kiss K, Bennedbæk FN, Nielsen FC.

J Mol Endocrinol. 2012 Jan 25;48(1):11-23. doi: 10.1530/JME-11-0039. Print 2012 Feb.

PMID:
22049245
7.

MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.

Lima CR, Geraldo MV, Fuziwara CS, Kimura ET, Santos MF.

BMC Cancer. 2016 Feb 16;16:108. doi: 10.1186/s12885-016-2146-z.

8.

Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.

Colamaio M, Calì G, Sarnataro D, Borbone E, Pallante P, Decaussin-Petrucci M, Nitsch L, Croce CM, Battista S, Fusco A.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2168-78. doi: 10.1210/jc.2012-1929. Epub 2012 Sep 10.

PMID:
22965940
9.
10.

A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.

Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C.

J Clin Endocrinol Metab. 2006 Sep;91(9):3584-91. Epub 2006 Jul 5.

PMID:
16822819
11.

microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.

Carvalheira G, Nozima BH, Cerutti JM.

Oncotarget. 2015 Sep 29;6(29):28357-70. doi: 10.18632/oncotarget.4947.

12.

Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.

Ulivieri A, Lavra L, Dominici R, Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis T, Jia-Jing L, Larsson C, Bartolazzi A, Sciacchitano S.

J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.

PMID:
18306168
13.

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

Lassalle S, Hofman V, Ilie M, Bonnetaud C, Puisségur MP, Brest P, Loubatier C, Guevara N, Bordone O, Cardinaud B, Lebrigand K, Rios G, Santini J, Franc B, Mari B, Al Ghuzlan A, Vielh P, Barbry P, Hofman P.

Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.

14.

The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.

Jikuzono T, Kawamoto M, Yoshitake H, Kikuchi K, Akasu H, Ishikawa H, Hirokawa M, Miyauchi A, Tsuchiya S, Shimizu K, Takizawa T.

Int J Oncol. 2013 Jun;42(6):1858-68. doi: 10.3892/ijo.2013.1879. Epub 2013 Apr 2.

15.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

16.

The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness.

Zwanziger D, Badziong J, Ting S, Moeller LC, Schmid KW, Siebolts U, Wickenhauser C, Dralle H, Fuehrer D.

Endocr Relat Cancer. 2015 Oct;22(5):819-30. doi: 10.1530/ERC-14-0502. Epub 2015 Jul 28.

17.

MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.

Ma Y, Qin H, Cui Y.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):958-63. doi: 10.1016/j.bbrc.2013.11.010. Epub 2013 Nov 9.

PMID:
24220341
18.

Expression of miR-100 and RBSP3 in FTC-133 cells after exposure to 131I.

Zhang S, Deng B, Zhang Y, Jiang N.

Nucl Med Commun. 2014 Sep;35(9):932-8. doi: 10.1097/MNM.0000000000000142.

PMID:
24785011
19.

miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis.

Stokowy T, Wojtaś B, Fujarewicz K, Jarząb B, Eszlinger M, Paschke R.

Horm Metab Res. 2014 Mar;46(3):171-80. doi: 10.1055/s-0033-1363264. Epub 2014 Jan 20.

PMID:
24446156
20.

MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.

Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, Nikiforova MN.

Ann Surg Oncol. 2011 Jul;18(7):2035-41. doi: 10.1245/s10434-011-1733-0. Epub 2011 May 3.

Supplemental Content

Support Center